Optimizing Operations for Plasma Centers
We offer innovative technologies that enable higher plasma yield collections, improve productivity and quality in our customers’ centers, and enhance the overall donor experience.
Advancing Patient Care at Hospitals
We provide information and solutions that enable healthcare professionals to improve patient care and economic outcomes in critical settings.
Driving Efficiency for Blood Centers
We advance products and services to help
ensure blood safety, improve operational efficiency and collect the blood components in the greatest demand.
Join Our Winning Team
At Haemonetics, the work you do matters. Join us in advancing healthcare while you advance your own career and make your ideas, commitment and passion matter every day.
Making Our Work Matter
We develop innovative medical technology products and services that improve the quality, effectiveness and efficiency of care. We are building a collaborative, performance-driven culture that attracts and develops the best talent.
Guided by Purpose
At Haemonetics, our Purpose inspires the important work we do every day to meaningfully advance patient care and drive greater possibilities in healthcare. How we do this work is equally important. We are guided by our Purpose, and mindful of our shareholders, customers, employees and other key stakeholders whose trust we value. We are committed to being a good corporate citizen and take responsibility to proactively identify and manage the environmental, social and governance risks and opportunities that are relevant to our business and those we serve.
The LatestView all News
Haemonetics Earns CE Mark for VASCADE® Vascular Closure Product Portfolio
September 12, 2022
Haemonetics Announces Agreement to Offer Enhanced Transfusion Management Software to Epic's Global Network of Hospitals
August 29, 2022
Haemonetics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
August 23, 2022
Haemonetics 1st Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
August 10, 2022